rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Enoch Kariuki

Director

Company insider

Files Form 4 as: Director, Zentalis Pharmaceuticals; Director, Imago BioSciences.

Every Form 4 they filed

In numbers

Trades disclosed
12
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
9 Feb 2021
Last trade
16 Jun 2026
Last filed
18 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ZNTL Zentalis PharmaceuticalsDirector · Biotechnology · last 16 Jun 20260 buys · 0 sells
Imago BioSciencesDirector · last 11 Jan 20230 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
16 Jun 2026filed 18 Jun 2026ZNTL Zentalis PharmaceuticalsBiotechnologySEC FORM 4 Code A—57,100 at $0.00filing
16 Jun 2026filed 18 Jun 2026ZNTL Zentalis PharmaceuticalsBiotechnologySEC FORM 4 Code A—57,100 at $0.00filing
17 Jun 2025filed 18 Jun 2025ZNTL Zentalis PharmaceuticalsBiotechnologySEC FORM 4 Code A—57,603 at $0.00filing
21 Jun 2024filed 21 Jun 2024ZNTL Zentalis PharmaceuticalsBiotechnologySEC FORM 4 Code A—41,581 at $0.00filing
16 Jun 2023filed 16 Jun 2023ZNTL Zentalis PharmaceuticalsBiotechnologySEC FORM 4 Code A—16,364 at $0.00filing
11 Jan 2023filed 11 Jan 2023Imago BioSciencesoption or derivativeSEC FORM 4 Code D—119,047filing
11 Jan 2023filed 11 Jan 2023Imago BioSciencesoption or derivativeSEC FORM 4 Code D—23,809filing
11 Jan 2023filed 11 Jan 2023Imago BioSciencesoption or derivativeSEC FORM 4 Code D—11,904filing
8 Jun 2022filed 10 Jun 2022ZNTL Zentalis PharmaceuticalsBiotechnologySEC FORM 4 Code A—21,817 at $0.00filing
1 Jun 2022filed 3 Jun 2022Imago BioSciencesoption or derivativeSEC FORM 4 Code A—11,904 at $0.00filing
15 Jul 2021filed 19 Jul 2021Imago BioSciencesoption or derivativeSEC FORM 4 Code A—23,809 at $0.00filing
9 Feb 2021filed 10 Feb 2021ZNTL Zentalis Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—42,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Ingmar BrunsChief Medical Officer · Chief Medical Officer at Zentalis Pharmaceuticals, filing Form 4 there in the last year
WALTERS GROUP10% owner · 10% owner at Zentalis Pharmaceuticals, filing Form 4 there in the last year
Luke Nathaniel WalkerDirector · Director at Zentalis Pharmaceuticals, filing Form 4 there in the last year
Scott Dunseth MyersDirector · Director at Zentalis Pharmaceuticals, filing Form 4 there in the last year
David Michael JohnsonDirector · Director at Zentalis Pharmaceuticals, filing Form 4 there in the last year